Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms. Systchenko T, Chomel JC, Gallego-Hernanz P, Moya N, et al. Br J Haematol 2023;202:284-288.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Systchenko T, Chomel JC, Gallego-Hernanz P, Moya N, et al. Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms. Br J Haematol 2023;202:284-288.
PMID: 37183377